Literature DB >> 10675855

Meniscus Tears: Treatment in the Stable and Unstable Knee.

.   

Abstract

Basic science research and follow-up studies after meniscectomy have provided convincing evidence of the importance of preservation of the meniscus in decreasing the risk of late degenerative changes. Whether in a stable or an unstable knee, if a meniscus tear cannot be repaired, a conservative partial meniscectomy should be undertaken to preserve as much meniscal tissue as possible. When feasible, repair should be carried out in young patients with an isolated meniscus tear, despite healing rates that are significantly lower than those obtained when meniscus repair is done with anterior cruciate ligament (ACL) reconstruction. The incidence of successful healing is inversely related to the rim width and tear length. In general, meniscus repair should be limited to patients under 50 years of age. Vertical longitudinal tears, including bucket-handle tears, are most amenable to repair. Some radial split tears can be repaired. In an ACL-deficient knee, meniscus repair is more prone to failure if not performed in conjunction with an ACL reconstruction, and is not recommended. Meniscal allograft surgery is investigational but may hold promise for selected patients.

Entities:  

Year:  1993        PMID: 10675855     DOI: 10.5435/00124635-199309000-00006

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  14 in total

1.  Rehabilitation following meniscal repair.

Authors:  John T Cavanaugh; Sarah E Killian
Journal:  Curr Rev Musculoskelet Med       Date:  2012-03

Review 2.  Complications in brief: meniscus repair.

Authors:  F Winston Gwathmey; S Raymond Golish; David R Diduch
Journal:  Clin Orthop Relat Res       Date:  2012-07       Impact factor: 4.176

3.  A history of meniscal surgery: from ancient times to the twenty-first century.

Authors:  B Di Matteo; C J Moran; V Tarabella; A Viganò; P Tomba; M Marcacci; R Verdonk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-08-01       Impact factor: 4.342

4.  Mid-term clinical results of medial meniscus repair with the meniscus arrow in the unstable knee.

Authors:  Nikolaos Koukoulias; Stergios Papastergiou; Konstantinos Kazakos; Georgios Poulios; Konstantinos Parisis
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2006-09-12       Impact factor: 4.342

5.  Meniscal repair with concurrent anterior cruciate ligament reconstruction: operative success and patient outcomes at 6-year follow-up.

Authors:  Robert W Westermann; Rick W Wright; Kurt P Spindler; Laura J Huston; Brian R Wolf
Journal:  Am J Sports Med       Date:  2014-07-14       Impact factor: 6.202

Review 6.  Meniscal repair outcomes at greater than five years: a systematic literature review and meta-analysis.

Authors:  Jeffrey J Nepple; Warren R Dunn; Rick W Wright
Journal:  J Bone Joint Surg Am       Date:  2012-12-19       Impact factor: 5.284

7.  Clinical results of meniscus repair with the meniscus arrow: a 4- to 8-year follow-up study.

Authors:  Nikolaos Koukoulias; Stergios Papastergiou; Konstantinos Kazakos; Georgios Poulios; Konstantinos Parisis
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2006-07-21       Impact factor: 4.342

8.  Expression of β-defensin-4 in "an in vivo and ex vivo model" of human osteoarthritic knee meniscus.

Authors:  Giuseppe Musumeci; Maria Luisa Carnazza; Rosalia Leonardi; Carla Loreto
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-08-31       Impact factor: 4.342

9.  AN ALTERNATIVE APPROACH TO THE TREATMENT OF MENISCAL PATHOLOGIES: A CASE SERIES ANALYSIS OF THE MULLIGAN CONCEPT "SQUEEZE" TECHNIQUE.

Authors:  Robinetta Hudson; Amy Richmond; Belinda Sanchez; Valerie Stevenson; Russell T Baker; James May; Alan Nasypany; Don Reordan
Journal:  Int J Sports Phys Ther       Date:  2016-08

10.  Outcomes of meniscal preservation using all-inside meniscus repair devices.

Authors:  Sujith Konan; Fares S Haddad
Journal:  Clin Orthop Relat Res       Date:  2010-05       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.